Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  defined green tea catechin extract
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000454773, P30CA015083, 1155-05, NCI-2009-01227, MC0419, MAYO-MC0419, 7303, NCI-7303, CLLT-MAYO-MC0419, NCT00262743
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000377681, P30CA016042, UCLA-0301091-03, NCT00088946
Phase II Randomized Study of Green Tea Extract (Polyphenon E®) for the Prevention of Cervical Cancer in Patients With Human Papillomavirus (HPV) and Low-Grade Cervical Intraepithelial Neoplasia (CIN 1)
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UARIZ-UAZ03-1-02, UARIZ-HSC-0540, UAZ03-1-02, NCT00303823
Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: CDR0000487501, U01CA101204, P30CA023074, UARIZ-HSC-0353, NCT00363805
Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 45 to 74
Sponsor: NCI, Other
Protocol IDs: CDR0000578191, P01CA096964, BCCA-H03-61083, BCCA-R03-1083, H03-61083, NCT00573885
Green Tea Extract and Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: H04-176, NCT00676780
Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 80
Sponsor: NCI, Other
Protocol IDs: MCC-15008, R01 CA12060-01A1, NCT00596011
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 to 75
Sponsor: Other
Protocol IDs: H04-179, NCT00676793
Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: MC084C, NCI-2012-00058, NCT01606124
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00894, HSC # 06-0695-04, N01CN35158, CDR0000538554, UARIZ-UAZ05-6-01, UAZ05-6-01, UARIZ-HSC-06-0695-04, NCT00459407
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
Phase: Phase I
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00855, CDR0000653460, CDR0000429486, IRB-AAAB0407, 2004-0907, MDA03-1-01, N01CN35159, P30CA013696, MDA-2004-0907, CPMC-AAA0407, NCT00233935
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Completed
Age: 21 to 65
Sponsor: NCI
Protocol IDs: NCI-2009-00858, IRB-AAAB7638, CDR0000653465, 2006-0521, MDA04-4-01, P30CA016672, N01CN35159, MDA-MDA04-4-01, MDA-2006-0521, CPMC-IRB-AAAB7638, NCT00516243
Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants
Phase: Phase I
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000387801, P30CA023074, UARIZ-HSC-0499, NCT00091325
Start Over